BlueWind Medical raises $47.8m to advance commercialisation efforts for UUI treatment
BlueWind plans to use the funds for expanding sales functions and market access initiatives for its Revi implantable tibial neuromodulation system.
15 May 2026
15 May 2026
BlueWind plans to use the funds for expanding sales functions and market access initiatives for its Revi implantable tibial neuromodulation system.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.